EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma

Yannick Foerster iD, Kristine E Mayer iD, Tilo Biedermann, Oana-Diana Persa iD

Experimental Dermatology · 2025

DOI: 10.1111/exd.70185 ↗

At a glance

Journal article in Experimental Dermatology, 2025. Written by Yannick Foerster and 3 co-authors. Institution: Department of Dermatology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany. Major MEDLINE topics: Receptor Tyrosine Kinase-like Orphan Receptors, Skin Neoplasms, Carcinoma, Squamous Cell. 47 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cutaneous squamous cell carcinoma (cSCC) is a common type of skin cancer, predominantly affecting elderly and immunosuppressed patients. Despite recent therapeutic advances, including the introduction of immune checkpoint inhibitors, outcomes for patients with metastatic or recurrent disease remain poor, underscoring the need for new therapeutic approaches and reliable biomarkers to identify patients at high risk of progression. In this context, receptor tyrosine kinase‐like orphan receptor 1 (ROR1), previously associated with poor prognosis and targeted therapeutically in other malignancies, has not yet been investigated in cSCC. This study aimed to evaluate ROR1 expression in cSCC and investigate its potential role as a biomarker for tumour aggressiveness. ROR1 expression was analysed via immunofluorescence in a tissue microarray of 360 cSCC samples from a biobank cohort at the University Hospital Cologne. Fluorescence intensity was quantified and correlated with clinicopathologic features and patient outcomes. High ROR1 expression was detected in 42.5% of samples, predominantly localised at tumour invasive fronts. Elevated ROR1 levels were significantly associated with poor tumour differentiation ( p < 0.001), lymph node metastasis ( p = 0.007), and perineural invasion ( p = 0.005). Although higher ROR1 expression correlated with worse progression‐free and metastasis‐free survival, these differences did not reach statistical significance. In conclusion, this study identifies ROR1 as a novel marker of aggressive cSCC, linked to poor differentiation, lymphatic spread and perineural invasion. ROR1 holds potential both as a prognostic biomarker and as a therapeutic target, encouraging future exploration of ROR1‐directed therapies in advanced cSCC.

Subjects

MeSH terms (MEDLINE)

Receptor Tyrosine Kinase-like Orphan ReceptorsSkin NeoplasmsCarcinoma, Squamous CellHumansFemaleMaleAgedMiddle AgedNeoplasm InvasivenessAged, 80 and overCell DifferentiationBiomarkers, TumorAdultLymphatic MetastasisPrognosis

Author keywords

ROR1cutaneous squamous cell carcinomaskin cancertyrosine kinase

Substances

Receptor Tyrosine Kinase-like Orphan ReceptorsROR1 protein, humanBiomarkers, Tumor

Authors and institutions

  • Department of Dermatology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Department of Dermatology, University Hospital Cologne and Medical Faculty, Cologne, Germany.

ORCID profiles: Yannick Foerster, Kristine E Mayer, Oana-Diana Persa

Cite

APA

Foerster, Y., Mayer, K. E., Biedermann, T., & Persa, O. D. (2025). High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma. Experimental Dermatology. https://doi.org/10.1111/exd.70185

Vancouver

Foerster Y, Mayer KE, Biedermann T, Persa OD. High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma. Experimental Dermatology. 2025. doi:10.1111/exd.70185

BibTeX
@article{Foerster2025,
  author = {Foerster, Yannick and Mayer, Kristine E and Biedermann, Tilo and Persa, Oana-Diana},
  title = {High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma},
  journal = {Experimental Dermatology},
  year = {2025},
  doi = {10.1111/exd.70185}
}
Start for free →